Company intelligence / Profile preview
LakeShore Biopharma Co., Ltd
Beijing, Chinaysbiopharm.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
LakeShore Biopharma has a marketed rabies vaccine (YSJA) with over 100M doses sold. The company is conducting Phase III trials for simplified regimens of YSJA and for its PIKA Rabies Vaccine. Other products in the pipeline include treatments for cancer and other infectious diseases at various clinical stages.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccinesTherapeutic biologics
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
Beyond the preview
Go deeper on LakeShore Biopharma Co., Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LakeShore Biopharma Co., Ltd.